The 2025 AAD Annual Meeting will feature over 300 sessions across six dermatology categories, including inflammatory dermatoses and melanoma. Late-breaking research sessions will present new clinical ...
Merck is the pharmaceutical company that makes a medication called pembrolizumab (Keytruda), which is used to treat different ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Dr ...
Since its launch in 2022, a major focus of the Academy’s Your Dermatologist Knows consumer positioning strategy has been the ...
Please provide your email address to receive an email when new articles are posted on . Susan C. Taylor, MD, FAAD, assumed her role as president at the AAD annual meeting. She said her mission is to ...
Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results